| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |